Piramal Pharma has appointed OMD India, part of Omnicom Media Group, as its integrated media agency after a multi-round pitch. OMD India will handle the marketing and media efforts for Piramal Pharma’s portfolio of over-the-counter (OTC) brands, including Lacto Calamine, Little’s, Tetmosol, Polycrol, and Women’s intimate health range. The agency will be responsible for enhancing the brand’s presence, driving consumer engagement, and creating an impact-driven marketing strategy to drive business growth.
OMD India will manage the account out of its Mumbai office, bringing its expertise in media and digital innovation to create a game plan to boost brand salience and drive business growth. Anisha Iyer, CEO of OMD India, noted that the partnership represents a significant opportunity to leverage the agency’s strategic acumen and market intelligence to elevate Piramal’s portfolio of brands to new heights.
This win is a significant milestone for OMD India, building on its recent success, including winning the integrated media mandate for HDFC Life in January 2025. The partnership with Piramal Pharma is expected to further strengthen OMD India’s presence in the market. With this move, Piramal Pharma aims to create a lasting impression on consumers across India and shape a future of sustained growth and impact.